US FDA nicotine cap proposal: optimism in the face of uncertainty, delays, lawsuits

The US Food and Drug Administration (FDA) expects its new proposal for a very low nicotine cap on conventional cigarettes to be a net positive for alternative nicotine products.

The proposal still needs to go through a further consultation and review process. The comment period will extend to 15th September and include referring the proposal to the Tobacco Product Scientific Committee for a public meeting. The proposed rule will also have to survive a change in government leadership as well as civil service leadership to one that may prove less amenable to maintaining work on it.

Read full article
I'm already a subscriber

Freddie Dawson

Senior news editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the TobaccoIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation